Cognitive Behavioral Therapy & Medication Adherence in Schizophrenia

This report evaluates the experiences of Cognitive Behavioral Therapy (CBT) in enhancing medication adherence among patients diagnosed with schizophrenia. It begins with an introduction to schizophrenia, its symptoms, causes, and treatments, emphasizing the importance of medication adherence. The study's objectives include understanding schizophrenia, identifying the benefits of CBT, and assessing its effectiveness in improving medication adherence. The report reviews search strategies, including databases like Google Scholar, PubMed, and others, focusing on articles published between 2015 and 2021. The methodology includes a PICO framework and critical appraisal using the CASP tool. The report synthesizes data from three selected studies, discussing the findings and concluding that CBT is an effective intervention for improving medication adherence in schizophrenia patients. The discussion section delves into the implications of CBT and its impact on patient outcomes, while the conclusion summarizes the key findings and suggests areas for future research.